Market revenue in 2023 | USD 36.5 million |
Market revenue in 2030 | USD 121.7 million |
Growth rate | 18.8% (CAGR from 2023 to 2030) |
Largest segment | Cytokines & growth factors |
Fastest growing segment | Cytokines & Growth Factors |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Cytokines & Growth Factors, Antibodies, Immune checkpoint proteins, Virus Antigens, Enzymes, Recombinant Regulatory Protein, Hormones |
Key market players worldwide | Thermo Fisher Scientific Inc, Danaher Corp, Bio-Techne Corp, Sino Biological, Miltenyi Biotec, Proteintech Group, Prospec, New England Biolabs |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to research-grade proteins market will help companies and investors design strategic landscapes.
Cytokines & growth factors was the largest segment with a revenue share of 22.74% in 2023. Horizon Databook has segmented the India research-grade proteins market based on cytokines & growth factors, antibodies, immune checkpoint proteins, virus antigens, enzymes, recombinant regulatory protein, hormones covering the revenue growth of each sub-segment from 2018 to 2030.
Companies & organizations are undertaking several initiatives to increase awareness and accessibility to research-grade proteins in the Indian market. For instance, in May 2023, researchers in the Department of Biological Sciences and Bioengineering at the Indian Institute of Technology Kanpur (IITK) revealed a regulatory mechanism for an essential category of drug targets called G Protein-coupled Receptors (GPCRs).
This discovery is important for understanding the fundamental mechanisms of cellular signaling within the body. Moreover, it can potentially streamline novel drug discovery processes for various disease conditions.
Moreover, according to a news article published by Economic Times Health World in July 2023, the interest in utilizing clinical trial sites in India has grown in the past few years. India holds a 3.4% share of the generic market and is ranked 14th globally in terms of market value.
Horizon Databook provides a detailed overview of country-level data and insights on the India research-grade proteins market , including forecasts for subscribers. This country databook contains high-level insights into India research-grade proteins market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account